Clearstead Advisors’s Sionna Therapeutics SION Stock Holding History
Bought
Maintained
Sold
Other funds holding SION
Clearstead Advisors's SION Position: Q3 2026 in Review
Clearstead Advisors opened a new position in Sionna Therapeutics (SION) in Q3 2026: 33 shares worth $174. The stake represents ﹤0.01% of the portfolio and ranks #3128 among its holdings.
136 funds tracked by Wall St. Rank hold SION as of Q3 2026.
- Clearstead Advisors held 33 shares of Sionna Therapeutics worth $174 as of Q3 2026.
- Sionna Therapeutics was a new Clearstead Advisors position in Q3 2026.
- Sionna Therapeutics made up ﹤0.01% of Clearstead Advisors's portfolio in Q3 2026, its #3128 holding.
- 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.
Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.